Inkef Capital
Overview
Inkef Capital is a venture capital firm based in Amsterdam, backing promising early-stage companies in Europe. The firm focuses on sectors such as life sciences, health technology, digital technology (including SaaS and AI), and industrial technology. INKEF Capital plays a pivotal role in supporting innovative companies with disruptive technologies and scalable business models, typically investing in Seed and Series A rounds, and occasionally in Series B. Beyond financial backing, INKEF Capital provides strategic guidance and operational support to its portfolio companies, leveraging a broad network of industry experts and advisors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| TargED Biopharmaceuticals | Jun 2026 | Series A Extension | Co-investor |
| Quantum Motion | May 2026 | Series C | Co-investor |
| Silverflow | Mar 2026 | Series B | Co-investor |
| ViCentra | Sep 2025 | Series D | Co-investor |
| Salvia BioElectronics | May 2025 | Series B | Co-investor |
Key People
Reitze Douma
Managing Partner
Simone Botti
Senior Partner, Head Of Healthcare
Hendrik Jan ten Have
Strategic Sparring Partner
Ivan Burkov
Junior Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
